In the vast field of health and wellness, the pursuit of longevity and maintaining our youth has remained constant. The quest isn’t just for more years but for better ones, full of vibrancy and energy. This crucial distinction underlines the latest breakthrough in the anti-aging sector. This development goes beyond the traditional focus on masking age-related symptoms, opting instead to address the foundational causes of aging.
One such development is RESTORIN, a new product from Seragon Biosciences, a biopharmaceutical firm recognized for its dedication to scientific innovation, collaboration, and the design of life-enhancing products.
Yet, Seragon’s RESTORIN shines the brightest among them all. Much more than other products in the wellness market, it was developed with direct support from world-renowned institutions like Harvard University and the Mayo Clinic.
Firstly, it harnesses the power of senolytic agents. These compounds selectively target senescent cells, the worn-out cells that can contribute to inflammation and reduced tissue function.
“The accumulation of senescent cells in our body is related to the progression of many age-related diseases,” says David Brown, Ph.D., senior scientist at Seragon Biosciences, who helped develop RESTORIN. “By employing senolytics, our product successfully helps the body address these dysfunctional cells.”
Alongside the senolytic agents, RESTORIN incorporates NAD+ precursors. NAD+, or nicotinamide adenine dinucleotide, is a coenzyme found in every cell in our bodies. It plays a pivotal role in energy metabolism and maintaining DNA integrity. As we age, our NAD+ levels start to decline. Consuming NAD+ precursors has been shown to significantly increase NAD+ levels. By boosting NAD+ levels, you ensure your cells have what they need to function optimally.
Next are sirtuin-activating compounds (STACs). Dr. Brown explains that sirtuins are proteins that play an important role in cellular health and longevity. They influence a variety of bodily functions, including DNA repair and cellular energy metabolism.
The lynchpin in RESTORIN is arguably the advanced SERC targeted release technology. This allows for the controlled release of the active compounds into the GI tract, ensuring efficient absorption.
“The product’s effectiveness lies not only in its individual components but rather in their complementary functions and collective impact,” says Dr. Brown. “The targeted release technology further enhances this by ensuring they are properly absorbed.”
Looking ahead, Dr. Brown and his team are steadfast in their commitment to medical innovation and research. With a mission to revolutionize the anti-aging landscape, they’ve already made significant strides at Seragon with RESTORIN. And, considering the product’s focus on targeting the root causes of aging instead of simply masking the symptoms, the future for institutions like Seragon is bright.
Dr. Brown says, “We need to stay committed, as a scientific community, to the research and development of comprehensive and holistic solutions that will consider all aspects of human health — and aging — instead of focusing on only one. With RESTORIN, we are one step closer to a future where people can live healthier, longer lives.”
Brianna Ruelas is a Dallas-based account executive and news desk editor at Grit Daily. She is also a motivational speaker and singer, creative cultivator, and bestselling author. Reach her at [email protected].
Credit: Source link
Comments are closed.